ad image

Positive CHMP Opinion

1 / 1
Array BioPharma
Clinical Data

BRAFTOVI™ (encorafenib) + MEKTOVI® (binimetinib) Receives Positive CHMP Opinion for Advanced BRAF-mutant Melanoma

Array BioPharma

PR-M08-18-NI-010Aug 02, 2018
Pierre Fabre
Positive Opinion

Pierre Fabre receives positive CHMP opinion for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) in adult patients with advanced BRAF-mutant melanoma

Pierre Fabre

PR-M08-18-NI-008Aug 02, 2018
Janssen Pharmaceutical Companies
Positive Opinion

Janssen Receives Positive CHMP Opinion for Darzalex®▼ (daratumumab) as Frontline Treatment for Newly Diagnosed Patients with Multiple Myeloma

Janssen Pharmaceutical Companies

PR-M08-18-NI-007Aug 02, 2018
Mylan
Biosimilar

Mylan and Fujifilm Kyowa Kirin Biologics Announce Positive CHMP Opinion for Hulio™, Biosimilar Adalimumab

Mylan

PR-M08-18-NI-001Aug 01, 2018
1 / 1